Company
Pfizer Inc
NYSE:PFE
Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.
293 stories · page 1 of 3
Pfizer more than doubles price of Covid vaccine
Paxlovid has been supplied free to patients since the onset of the pandemic
Nobel for mRNA: Which other biotech stocks might be overlooked?
Katalin Karikó and Drew Weissman’s nucleoside base modification technology (licensed to drug companies Pfizer and Moderna for Covid-19 vaccines)—became the recipient of a Nobel prize this week. Which other biotech companies might be worth l
Pfizer legal woes continue with battle against Moderna
Pfizer and BioNTech are countersuing rival Moderna in a legal battle over the development of covid vaccines
Pfizer raises sales forecasts, despite ongoing legal challenges
Pfizer hiked annual forecasted sales of its COVID-19 vaccine by US$2bn, despite extensive legal trouble
Pfizer raises price of Covid vaccine in US by four-fold
A director told Reuters the new price for the jab will be around US$110-130 compared to US$30 currently
Pfizer to buy Global Blood Therapeutics for US$5.4bn
Pfizer gets Oxybryta and two other pipeline assets with the acquisition - and approved GBT drugs are expected to generate over US$3bn in sales annually at their peak
BioNTech and Pfizer in talks to delay Covid vaccine deliveries amid EU glut
A contract has been signed with the EU for up to 1.8bn doses of the jab, though the contract only extends to 2023
BioNTech sued by CureVac over its mRNA technology
BioNTech and two subsidiaries have been accused of infringing on the Germany-based biotech company's intellectual property rights, with Curevac seeking 'fair compensation'
Pfizer pledges not to make a profit on third world vaccines in future
The pharmaceutical company made $42.6bn from the sale of vaccines in 2021
Pfizer/BioNTech say third vaccine dose is 80% effective against Omicron in kids 5 and younger
According to clinical trial results released Monday, a third vaccine dose was well tolerated by the children, and most side effects were mild to moderate
Pfizer splashes $11.6bn of vaccine cash on Biohaven Pharmaceutical Holding
Will this be the start of the predicted rash of biotech M&A activity?
Pfizer accused of profiteering after reporting further leap in Covid vaccine sales
Other companies such as AstraZeneca and Johnson & Johnson priced their vaccines at cost during the pandemic
Pfizer leaves 2022 COVID-19 product sales forecasts unchanged in 1Q report
The firm previously increased its guidance for vaccine sales after each quarter in 2021
Moderna requests emergency approval for a second Covid booster for all adults
The request was based in part on recent data from the United States and Israel regarding how well the Moderna shot warded off the Omicron variant of the Corona virus
Archive
Wall Street closes higher as investors await inflation data
The Nasdaq Composite was up by 1.3% at 14,194, followed by the Dow Jones Industrial Average that rose by 1%, or 372 points at 35,463, while S&P 500 gained 0.8% at 4,521
Pfizer and BioNTech set to begin trials of Omicron specific vaccine
The proposed vaccine will be trialed among 1,420 adults between the ages of 18-55
Pfizer's COVID-19 pill given green light by the FDA
The FDA said the pill "is not a substitute for vaccination in individuals for whom COVID-19 vaccination and a booster dose are recommended"
UK cuts self-isolation for COVID-19 cases to 7 days
“We want to reduce the disruption from COVID-19 to people’s everyday lives,” said Secretary of State for Health and Social Care Sajid Javid
Pfizer's new oral treatment effective against Omicron says pharma
Boris Johnson warns his cabinet that a "huge spike" of the omicron variant is coming.
Pfizer's acquisition of Arena "shows big pharma's interest in cannabinoid medicines"
Arena was CBDX's fourth-largest holdings at the end of November, at 11.8%.
Pfizer and Moderna are best COVID-19 booster jabs, new study suggests
Britain decided to use only the Pfizer and Moderna jabs for its Covid-19 booster
Pfizer antiviral pill study shown to reduce risk of death from COVID-19 by 89%
The US pharmaceuticals company said it plans to submit the study data to the US Food and Drug Administration for Emergency Use Authorisation as soon as possible
COVID-19: Pfizer vaccine protection could drop to 20% after 5 months, study shows
The findings suggest that a large proportion of the vaccinated population could lose protection against infection in the coming months
COVID-19: Pfizer vaccine protection drops to 47% after six months
The reduction in the vaccine’s effectiveness against COVID-19 infection was due to its waning over time and not because of Delta or other variants
Pfizer and BioNTech to seek approval to vaccinate children after Covid study
Results were comparable to a previous Pfizer-BioNTech study in people 16 to 25 years of age immunised with three times larger doses
Coronavirus: Vaccine immunity starts waning after six months, study finds
Health experts are calling for the rollout of COVID-19 vaccine booster doses to keep protection levels high
US stocks finish higher on strong durable goods data
On the day, the Dow rose 39 points to 35,405, while the S&P 500 added 10 points at 4,496 and the tech-heavy Nasdaq edged up 22 points to 15,042.
Archive
The Pay Zone - Oil price, UJO/Egdon/Europa, Hunting, President, Prospex. And finally…
Oil price So, we’ve had a shakeout and yesterday saw a decent recovery, along with today’s rise Brent is nearly 8% off the lows which can be attributed to a number of factors. I would divide by country, firstly the USA where sentiment that
Coronavirus: US issues full approval for Pfizer vaccine
The approval is likely to trigger institutions, such as school and governmental bodies, to require vaccine certifications
Britain orders more Pfizer Covid-19 jabs as booster programme nears
Antibody tests will be freely available from tomorrow to people testing positive after a PCR test
US to recommend third COVID-19 vaccine dose as booster
An official announcement is expected as early as this week
US stocks finish strongly, add to record highs to end the week
The S&P 500 and Dow set intraday highs at Friday's close
Pfizer accused of abusing market position to overcharge NHS with 1,600% price hikes
Prices were lifted between 780% and 1,600% for the epilepsy drug than had previously been charged, with its UK distributor then selling the capsules at prices up to 2,600% higher than had been paid before
Pfizer asks for Covid-19 booster shot permission as UK infection rate jumps again
“The Pfizer vaccine is highly active against the Delta variant”
Pfizer treatment cuts severe Covid-19 deaths by 40% in trial
Xeljanz or tofacitinib is a new kind of drug known as a JAK inhibitor
Archive
Wall Street coasts to a comfortable close
The bulk of Monday's gains were achieved at or near the opening bell
Pharma companies to produce 11.4bn COVID-19 vaccine doses by year-end, says Goldman Sachs
Pfizer, AstraZeneca and Moderna will pump out a big chunk of the total